期刊文献+

肺结核患者CD3^+ CD56^+ NKT细胞对IL-2刺激的反应性研究

IL-2 stimulated responses of CD3^+ CD56^+ NKT cells in pulmonary tuberculosis patients
下载PDF
导出
摘要 目的:观察IL-2刺激后肺结核患者CD3+CD56+NKT细胞活化的规律和增殖情况。方法:结核病患者和健康人外周血单个核细胞用IL-2刺激和培养不同时间,采用多色荧光染色和流式细胞术检测NKT细胞的CD69的表达率以及培养前后NKT细胞数量的变化。结果:肺结核患者外周血NKT细胞的比率在刺激培养前与正常人比较无明显差异;经IL-2刺激0、8、16、40和64 h后,患者组和正常组NKT细胞表面CD69的表达量均显著增加,但患者组NKT细胞的CD69表达水平高于正常组(P<0.05);培养14 d后,患者组NKT细胞的数量扩增(108.69±59.22)倍,正常组NKT细胞的数量扩增(246.26±134.06)倍,明显高于患者组(P<0.05)。结论:肺结核患者外周血NKT细胞在IL-2刺激后表现为高度活化和低增殖的特点。 AIM: To observe the activation and proliferation characteristics of IL-2 stimulated CD3+CD56+ NKT cells in pulmonary tuberculosis(PTB) patients.METHODS: Peripheral blood mononuclear cells(PBMCs) from PTB patients and normal subjects were stimulated with IL-2 and cultured for different time points.The CD69 expression on and amount of the CD3+CD56+ NKT cells were detected by multi fluorescence staining and flow cytometry at different time of stimulation and culture.RESULTS: There was no significant difference in percentage of NKT cells between PTB patients and normal healthy controls before culture.When IL-2 was used to stimulate for 0 h,8 h,16 h,40 h and 64 h,the expression of CD69 on NKT cells in normal controls and PTB patients increased significantly,but the CD69 expression level of NKT cells in PTB patients was significantly higher than that in normal persons(P0.05).In PTB patients group,PBMCs were expanded significantly after stimulated by IL-2,the absolute number of NKT cells increased from(3.44±1.20)×104 to(323.23±75.98) ×104(P0.01),expanded by 108.69±59.22 fold,In normal control group the absolute number of NKT cells increased from(5.57±5.16)×104 to(1475.05±868.98)×104(P0.01),expanded by 246.26±134.06 fold,the expanding efficiency in PTB group was significantly lower than that in normal control group(P0.05).CONCLUSION: NKT cells in PTB patients present with high activation but low proliferation after stimulated by IL-2.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2010年第9期884-886,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 重大传染病防治科技重大专项(2008ZX10003011) 安徽省教育厅省高校重点实验室重点科研项目(2004Sys008)
关键词 肺结核 NKT细胞 IL-2 pulmonary tuberculosis(PTB) NKT cell IL-2
  • 相关文献

参考文献10

  • 1Jeevan A, Asherson GL. Recombinant interleukin-2 limits the replication of Mycobacterium lepraemurium and Mycobacterium boviz BCG in mice[J]. Lymphokine Res, 1988, 7(2) : 129.
  • 2Kaufmann SH, Ladel CH. Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium boris BCG[ J]. Immunobiology, 1994, 191(4-5): 509-519.
  • 3Xing Z, Wang J, Croitoru K, et al. Protection by CD4 or CD8 T cells against pulmonary Mycobacterium bovis bacillus Calmette-Guerin infection[J]. Infec Immun, 1998, 66( 11 ) : 5537 -5542.
  • 4Isabel SO, Asako C, Adaena G, et al. Innate invariant NKT cells recognize mycobacterium tuberculosis-infected macrophages, produce interferon-γ, and kill intracellular bacteria[J]. Plos Pathogens, 2008, 4(12): 1-9.
  • 5邬鹏,魏海明,田志刚.IL-2促进PBMC来源的NK、NKT、CD8^+ T细胞高表达NKG2D[J].中华微生物学和免疫学杂志,2006,26(8):684-687. 被引量:3
  • 6Schmidt-wolf IGH, Lefterova P, Johnston V, et al. Propagation of large numbers of T cells with natural killer cell markers [ J ]. Br J Haematol, 1994, 87(3) : 453 -458.
  • 7Chackerian A, Alt J, Perera V, et al. Activation of NKT cells protects mice from tuberculosis [ J ]. Immun Infect, 2002, 70 ( 11 ) : 6302 - 6309.
  • 8Montoya C J, Catano JC, Ramirez Z, et al. Invariant NKT ceils from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype[ J]. Clin Immuno, 2008, 127 ( 1 ) : 1 - 6.
  • 9Leite-de-Moraes MC, Herbelin A, Gouarin C, et al. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes [J]. J Immunol, 2000, 165(8) : 4367 -4371.
  • 10Lin Y, Roberts TJ, Wang CR, et al. Long-term loss of canonical NKT cells following an acute virus infection [ J ]. Eur J Immunol, 2005, 35 (3) : 879 - 889.

二级参考文献11

  • 1Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol, 2003, 3 (10): 781-790.
  • 2Groh V, Wu J, Yee C, et al. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature, 2002, 419(6908) : 734-738.
  • 3Wu JD, Higgins LM, Steinle A, et al. Prevalent expression of the immunostimulatory MHC class Ⅰ chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest, 2004, 114(4): 560-568.
  • 4Coudert JD, Zimmer J, Tomasello E, et al. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood, 2005, 106(5): 1711-1717.
  • 5Rosenberg SA, Mule JJ, Spiess PJ, et al. Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. J Exp Med, 1985,161(5): 1169-1188.
  • 6Lafreniere R, Rosenberg SA. Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (rIL-2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma. J Immunol, 1985,135(6) : 4273-4280.
  • 7Lu PH, Negrin ItS. A novel population of expanded human CD3^+ CD56^+ cells derived from T cells with potent in vivo antiturnor activity in mice with severe combined immunedeficiency. J Immunol, 1994, 153(4) : 1687-1696.
  • 8Mule JJ, Shu S, Rosenberg SA. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo. J Immunol,1985, 135(1): 646-652.
  • 9Salih HR, Rammensee HG, Steinle A. Cutting edge : down-regulation of MICA on human tumors by proteolytic shedding. J Immunol, 2002, 169(8) : 4098-4102.
  • 10Ogasawara K, Hamerman JA, Hsin H, et al. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity, 2003, 18(1) :41-51.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部